These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24252694)

  • 21. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers.
    Van Gessel Y; Klade CS; Putnak R; Formica A; Krasaesub S; Spruth M; Cena B; Tungtaeng A; Gettayacamin M; Dewasthaly S
    Vaccine; 2011 Aug; 29(35):5925-31. PubMed ID: 21723353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Japanese encephalitis virus induces vasodilation and severe lethality in adult and aged AG129 mice lacking alpha, beta and gamma interferon receptors.
    Siddqui G; Yadav N; Vishwakarma P; Thomas J; Khatri R; Kumar A; Tripathi A; Pramod RK; Vrati S; Samal S
    Virus Res; 2022 Oct; 319():198884. PubMed ID: 35931226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).
    Arroyo J; Guirakhoo F; Fenner S; Zhang ZX; Monath TP; Chambers TJ
    J Virol; 2001 Jan; 75(2):934-42. PubMed ID: 11134306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Construction of infectious Japanese encephalitis virus clone based on the cDNA template of the attenuated live vaccine production strain SA14-14-2].
    Zeng M; Jia LL; Yu YX; Dong GM; Liu WX; Wang ZW; Li DF
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):9-11. PubMed ID: 16201461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective immunity to Japanese encephalitis virus associated with anti-NS1 antibodies in a mouse model.
    Li Y; Counor D; Lu P; Duong V; Yu Y; Deubel V
    Virol J; 2012 Jul; 9():135. PubMed ID: 22828206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
    Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea.
    Kim DS; Houillon G; Jang GC; Cha SH; Choi SH; Lee J; Kim HM; Kim JH; Kang JH; Kim JH; Kim KH; Kim HS; Bang J; Naimi Z; Bosch-Castells V; Boaz M; Bouckenooghe A
    Hum Vaccin Immunother; 2014; 10(9):2656-63. PubMed ID: 25483480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Japanese encephalitis virus NS1-based vaccine: Truncated NS1 fused with E. coli heat labile enterotoxin B subunit.
    Wan J; Wang T; Xu J; Ouyang T; Wang Q; Zhang Y; Weng S; Li Y; Wang Y; Xin X; Wang X; Li S; Kong L
    EBioMedicine; 2021 May; 67():103353. PubMed ID: 33971403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus.
    Cao L; Fu S; Gao X; Li M; Cui S; Li X; Cao Y; Lei W; Lu Z; He Y; Wang H; Yan J; Gao GF; Liang G
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004686. PubMed ID: 27139722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection of SA14-14-2 live attenuated Japanese encephalitis vaccine against the wild-type JE viruses.
    Jia L; Wang Z; Yu Y
    Chin Med J (Engl); 2003 Jun; 116(6):941-3. PubMed ID: 12877812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rational design of a flavivirus vaccine by abolishing viral RNA 2'-O methylation.
    Li SH; Dong H; Li XF; Xie X; Zhao H; Deng YQ; Wang XY; Ye Q; Zhu SY; Wang HJ; Zhang B; Leng QB; Zuest R; Qin ED; Qin CF; Shi PY
    J Virol; 2013 May; 87(10):5812-9. PubMed ID: 23487465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Partially neutralizing potency against emerging genotype I virus among children received formalin-inactivated Japanese encephalitis virus vaccine.
    Fan YC; Chen JM; Chiu HC; Chen YY; Lin JW; Shih CC; Chen CM; Chang CC; Chang GJ; Chiou SS
    PLoS Negl Trop Dis; 2012; 6(9):e1834. PubMed ID: 23029592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children.
    Janewongwirot P; Puthanakit T; Anugulruengkitt S; Jantarabenjakul W; Phasomsap C; Chumket S; Yoksan S; Pancharoen C
    Vaccine; 2016 Oct; 34(44):5279-5283. PubMed ID: 27628323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.
    Hegde NR; Gore MM
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-18. PubMed ID: 28301270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sublingual immunization with Japanese encephalitis virus vaccine effectively induces immunity through both cellular and humoral immune responses in mice.
    Lee EY; Kim JY; Lee DK; Yoon IS; Ko HL; Chung JW; Chang J; Nam JH
    Microbiol Immunol; 2016 Dec; 60(12):846-853. PubMed ID: 28004418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of viremia formation between guinea-pigs infected with wild and attenuated (SA14-14-2) Japanese encephalitis viruses].
    Liu XY; Yu YX; Xu HS; Liang GD; Wang HY; Jia LL; Dong GM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Oct; 24(5):343-5. PubMed ID: 21280319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a live-attenuated chimeric vaccine against the emerging Usutu virus.
    Wang ZJ; Zhang RR; Wu M; Zhao H; Li XF; Ye Q; Qin CF
    Vaccine; 2024 Feb; 42(6):1363-1371. PubMed ID: 38310016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of live-attenuated Japanese encephalitis vaccine virus SA14-14-2.
    Yang D; Li XF; Ye Q; Wang HJ; Deng YQ; Zhu SY; Zhang Y; Li SH; Qin CF
    Vaccine; 2014 May; 32(23):2675-81. PubMed ID: 24709585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pre membrane and envelope protein is the crucial virulence determinant of Japanese encephalitis virus.
    Leng SL; Huang R; Feng YN; Peng LJ; Yang J; Li YH
    Microb Pathog; 2020 Nov; 148():104492. PubMed ID: 32916243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.